Home Amines 19420-57-6
19420-57-6,MFCD00050427
Catalog No.:AA01CCGP

19420-57-6 | 3,5,9-Trioxa-4-phosphaheptacosan-1-aminium,4,7-dihydroxy-N,N,N-trimethyl-10-oxo-, inner salt, 4-oxide, (7R)-

Pack Size
Purity
Availability
Price(USD)
Quantity
  
100mg
95%
in stock  
$85.00   $60.00
- +
250mg
≥98%
in stock  
$172.00   $120.00
- +
500mg
≥98%
in stock  
$322.00   $225.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA01CCGP
Chemical Name:
3,5,9-Trioxa-4-phosphaheptacosan-1-aminium,4,7-dihydroxy-N,N,N-trimethyl-10-oxo-, inner salt, 4-oxide, (7R)-
CAS Number:
19420-57-6
Molecular Formula:
C26H54NO7P
Molecular Weight:
523.6832
MDL Number:
MFCD00050427
SMILES:
CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(OCC[N+](C)(C)C)[O-])O
Properties
Computed Properties
 
Complexity:
546  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
1  
Heavy Atom Count:
35  
Hydrogen Bond Acceptor Count:
7  
Hydrogen Bond Donor Count:
1  
Rotatable Bond Count:
26  
XLogP3:
6.6  

Downstream Synthesis Route

[1]JournaloftheChemicalSociety.Chemicalcommunications,1990,p.1281-1282

[2]IndianJournalofChemistry-SectionBOrganicandMedicinalChemistry,1992,vol.31,p.824-827

[3]AngewandteChemie,1992,vol.104,p.1386-1387

[1]JournaloftheChemicalSociety.Chemicalcommunications,1990,p.1281-1282

[2]AngewandteChemie,1992,vol.104,p.1386-1387

[3]TetrahedronAsymmetry,1997,vol.8,p.451-458

[1]Bioscience,BiotechnologyandBiochemistry,1994,vol.58,p.1927-1928

[1]TetrahedronAsymmetry,1997,vol.8,p.451-458

302-79-4    19420-57-6   
1-stearoyl-2-all-trans-retinoyl-glycero-3-phosphorylcholine 

[1]SyntheticCommunications,1998,vol.28,p.2945-2958

Literature

Title: Insights into myalgic encephalomyelitis/chronic fatigue syndrome phenotypes through comprehensive metabolomics.

Journal: Scientific reports 20180101

Title: Lipidomic analyses of female mice lacking hepatic lipase and endothelial lipase indicate selective modulation of plasma lipid species.

Journal: Lipids 20140601

Title: Morphological effect of lipid carriers on permeation of lidocaine hydrochloride through lipid membranes.

Journal: International journal of pharmaceutics 20100330

Title: Quercetin prevents LPS-induced high-mobility group box 1 release and proinflammatory function.

Journal: American journal of respiratory cell and molecular biology 20091201

Title: Suppression of HMGB1 release by stearoyl lysophosphatidylcholine:an additional mechanism for its therapeutic effects in experimental sepsis.

Journal: Journal of lipid research 20050401

Title: Lysophosphatidylcholine enhances glucose-dependent insulin secretion via an orphan G-protein-coupled receptor.

Journal: Biochemical and biophysical research communications 20050128

Title: Atherogenic role of lysophosphatidylcholine in low-density lipoprotein modified by phospholipase A2 and in diabetic patients: protection by nitric oxide donor.

Journal: Metabolism: clinical and experimental 20030301

Title: Regulation of polymorphonuclear leukocyte degranulation and oxidant production by ceramide through inhibition of phospholipase D.

Journal: Blood 20020215

Title: How lysophosphatidylcholine inhibits cell-cell fusion mediated by the envelope glycoprotein of human immunodeficiency virus.

Journal: Virology 19970901

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:19420-57-6 Molecular Formula|19420-57-6 MDL|19420-57-6 SMILES|19420-57-6 3,5,9-Trioxa-4-phosphaheptacosan-1-aminium,4,7-dihydroxy-N,N,N-trimethyl-10-oxo-, inner salt, 4-oxide, (7R)-